期刊文献+

西洛他唑,PDEⅢ抑制剂:冠心病抗血小板治疗的新靶药 被引量:3

下载PDF
导出
摘要 动脉粥样硬化是一种系统性疾病,影响着心血管、脑血管以及外周动脉系统。心脏病发作和脑中风两种临床疾病表明,急性动脉血栓形成是其主要病因;同时成为世界上死亡率和患病率中最普通的疾病。血小板参与内皮中,
作者 蔡九妹 廖伟
出处 《赣南医学院学报》 2011年第3期493-495,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
  • 相关文献

参考文献38

  • 1yon Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease [J]. Circ Res ,2007 ,100 :27 - 40.
  • 2Nicswandt B. In vlvo thrombus formation in routine mod- els[J]. Circ Res,2007,100(7) :979 -991.
  • 3Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function[ J]. Circ Res,2007, I00 (12) : 1673 - 1685.
  • 4Tanabe Y, Ito E, Nakagawa I, et al. Effect of cilostazol on restenosis after coronary angioplasty and stenting in com- parison to conventional coronary artery stentlng with tlclo- pidine[J]. Int J Carcliol,2001,78(3) :285 -291.
  • 5Bhatt DL, Hirseh AT, Ringleb PA, et al. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopi-dog, el instead of aspirin CAPRIE in- vestigators [ J]. Am Heart J,2000,140( 1 ) :67 - 73.
  • 6Kim J, Lee K, Kim Y, et al. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel innormal controls: analysis with quantitative bleeding time and platelet aggregation test [ J ]. J Clin Neurosci, 2004, 11:600 -602.
  • 7Comerota AJ. Effect on platelet function of eilostazol, clo- pidogrel and aspirin, each alone or in combination [ J ]. Atheroscler Supp1,2005,6 : 13 - 19.
  • 8Abbas R, Chow CP, Browder N J, et al. In vitro metabo- lism and interaction of cilostazol with human hepatic cyto- chrome P450 isoforms [ J ]. Hum Exp Toxicol, 2000,19 : 178 - 184.
  • 9Hiatt WR, Money SR, Brass EP. Long-term safety of cilostazol in patients with peripheral atrery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects) J[J]. J Vasc Surg,2008,47(2) : 330-336.
  • 10Tedgui A, MaUat Z. Cytokines in atherosclerosis:patho- genic and regulatory pathways [ J ]. Physiol Rev, 2006, 86:515 -581.

二级参考文献10

共引文献5

同被引文献31

  • 1郝盼盼,陈玉国,张运.氯吡格雷抵抗相关因素的研究进展[J].心血管病学进展,2009,30(6):991-994. 被引量:21
  • 2陈研,吴小盈.2014 ACC/AHA非ST段抬高型急性冠脉综合征诊治指南概述——美国心脏病学院/美国心脏协会研究小组实践指南报告[J].创伤与急诊电子杂志,2014,2(2):35-40. 被引量:10
  • 3张妍,周玉杰,马长生,谢英,曹友兰,程秀琴,梁静.西洛他唑对阿司匹林抵抗现象干预的研究[J].中华医学杂志,2005,85(40):2850-2851. 被引量:8
  • 4Sabatine MS,Cannon CP,Gibson CM,et al.Addition of clopidogrelto aspirin and fibrinolytic therapy for myocardial infarction with st-se-gment elevation[J].N Engl J Med,2005,352(12):1179-1189.
  • 5Serebruany VL,Steinhubl SR,Berger PB,et al.Variability in plateletresponsiveness to clopidogrel among 544 individuals[J].J Am CollCardiol,2005,45(2):246-251.
  • 6Breet NJ,van Werkum JW,Bouman HJ,et al.Comparison of plateletfunction tests in predicting clinical outcom in patients undergoingcoronary stent impIantation[J].JAMA5 2010,303:754-762.
  • 7Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomiz-ed clinical trials of drug-eluting stents[J].N Engl J Med,2007,356(10):1020-1029.
  • 8Angiolillo DJ,Shoemaker SB,Desai B,et al.Randomized comparisonof a high clopidogrel maintenance dose in patients with diabetes melli-tus and coronary artery disease:Results of the optimizing antiplatelettherapy in diabetes mellitus(optimus)study[J].Circulation,2007,115(6):708-716.
  • 9Han Y,Li Y,Wang S,et al.Cilostazol in addition to aspirin and clopi-dogrel improves long-term outcomes after percutaneous coronary inte-rvention in patients with acute coronary syndromes:A randomized,co-ntrolled study[J].Am Heart J,2009,157⑷:733-739.
  • 10Shim CY,Yoon SJ,Park S,et al.The clopidogrel resistance can be att-enuated with triple antiplatelet therapy in patients undergoing drug-el-uting stents implantation[J].Int J Cardiol,2009,134(3):351-355.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部